1. Home
  2. EDSA vs VRME Comparison

EDSA vs VRME Comparison

Compare EDSA & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • VRME
  • Stock Information
  • Founded
  • EDSA 2015
  • VRME 1999
  • Country
  • EDSA Canada
  • VRME United States
  • Employees
  • EDSA N/A
  • VRME N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • VRME EDP Services
  • Sector
  • EDSA Health Care
  • VRME Technology
  • Exchange
  • EDSA Nasdaq
  • VRME Nasdaq
  • Market Cap
  • EDSA 13.8M
  • VRME 9.2M
  • IPO Year
  • EDSA N/A
  • VRME N/A
  • Fundamental
  • Price
  • EDSA $2.09
  • VRME $0.75
  • Analyst Decision
  • EDSA Strong Buy
  • VRME Strong Buy
  • Analyst Count
  • EDSA 2
  • VRME 2
  • Target Price
  • EDSA $13.00
  • VRME $1.38
  • AVG Volume (30 Days)
  • EDSA 13.1K
  • VRME 46.6K
  • Earning Date
  • EDSA 08-08-2025
  • VRME 08-12-2025
  • Dividend Yield
  • EDSA N/A
  • VRME N/A
  • EPS Growth
  • EDSA N/A
  • VRME N/A
  • EPS
  • EDSA N/A
  • VRME N/A
  • Revenue
  • EDSA N/A
  • VRME $22,903,000.00
  • Revenue This Year
  • EDSA N/A
  • VRME N/A
  • Revenue Next Year
  • EDSA N/A
  • VRME $5.93
  • P/E Ratio
  • EDSA N/A
  • VRME N/A
  • Revenue Growth
  • EDSA N/A
  • VRME N/A
  • 52 Week Low
  • EDSA $1.55
  • VRME $0.55
  • 52 Week High
  • EDSA $5.59
  • VRME $5.00
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.09
  • VRME 51.27
  • Support Level
  • EDSA $2.03
  • VRME $0.72
  • Resistance Level
  • EDSA $2.11
  • VRME $0.77
  • Average True Range (ATR)
  • EDSA 0.10
  • VRME 0.04
  • MACD
  • EDSA 0.01
  • VRME -0.00
  • Stochastic Oscillator
  • EDSA 73.33
  • VRME 56.52

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: